Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03241745
Title A Study of Nivolumab in Selected Uterine Cancer Patients
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

endometrial carcinoma

fallopian tube carcinosarcoma

endometrial stromal sarcoma

uterus leiomyosarcoma

ovarian carcinosarcoma

uterine cancer

uterine carcinosarcoma

Therapies

Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.